225 related articles for article (PubMed ID: 25374164)
1. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
[TBL] [Abstract][Full Text] [Related]
2. [Advances in cancer proteomics study].
Chen ZC
Ai Zheng; 2004 Feb; 23(2):113-7. PubMed ID: 14960226
[TBL] [Abstract][Full Text] [Related]
3. Translational Research and Plasma Proteomic in Cancer.
Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
[TBL] [Abstract][Full Text] [Related]
4. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
Sung HJ; Cho JY
BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
[TBL] [Abstract][Full Text] [Related]
6. Proteomics of ovarian cancer: functional insights and clinical applications.
Elzek MA; Rodland KD
Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
[TBL] [Abstract][Full Text] [Related]
7. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries.
Boschetti E; D'Amato A; Candiano G; Righetti PG
J Proteomics; 2018 Sep; 188():1-14. PubMed ID: 28882677
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics and breast cancer.
Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in ovarian cancer.
Tung CS; Wong KK; Mok SC
Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
[TBL] [Abstract][Full Text] [Related]
10. Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis.
Gasparri R; Sedda G; Noberini R; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2020 Sep; 14(5):e1900138. PubMed ID: 32418314
[TBL] [Abstract][Full Text] [Related]
11. [Research Progress of Biomakers Proteomics-based in Lung Cancer].
Xie H; Chen Z; Wang G
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):391-6. PubMed ID: 26104898
[TBL] [Abstract][Full Text] [Related]
12. [Proteomics and biomarkers for detection of ovarian cancer].
Kacerovský M; Tambor V; Lenco J; Tosner J
Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer biomarker screening: still too early to tell.
Anderson GL
Womens Health (Lond); 2010 Jul; 6(4):487-90. PubMed ID: 20597610
[No Abstract] [Full Text] [Related]
14. BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
Mundhofir FE; Wulandari CE; Prajoko YW; Winarni TI
Asian Pac J Cancer Prev; 2016; 17(3):1539-46. PubMed ID: 27039803
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
16. Proteins' promise--progress and challenges in ovarian cancer proteomics.
Koehn H; Oehler MK
Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
[TBL] [Abstract][Full Text] [Related]
17. Stage at diagnosis and early mortality from cancer in England.
McPhail S; Johnson S; Greenberg D; Peake M; Rous B
Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
[TBL] [Abstract][Full Text] [Related]
18. Proteomics in cancer biomarkers discovery: challenges and applications.
Sallam RM
Dis Markers; 2015; 2015():321370. PubMed ID: 25999657
[TBL] [Abstract][Full Text] [Related]
19. Mining CK2 in cancer.
Ortega CE; Seidner Y; Dominguez I
PLoS One; 2014; 9(12):e115609. PubMed ID: 25541719
[TBL] [Abstract][Full Text] [Related]
20. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers.
Souchelnytskyi S; Lomnytska M; Dubrovska A; Hellman U; Volodko N
Proteomics; 2006 Sep; 6 Suppl 2():65-8. PubMed ID: 17031801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
